Cisplatin versus non-cisplatin based first-line chemotherapy for advanced urothelial carcinoma previously treated with peri-operative cisplatin

INTRODUCTION: The optimal choice of first-line chemotherapy in urothelial carcinoma (UC) patients who relapse after receiving peri-operative cisplatin-based chemotherapy (PCBC) is unclear. We investigated outcomes with cisplatin re-challenge vs. a non-cisplatin regimen in patients with recurrent met...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Genitourin Cancer
Main Authors: Locke, Jennifer A, Pond, Gregory Russell, Sonpavde, Guru, Necchi, Andrea, Giannatempo, Patrizia, Paluri, Ravi Kumar, Niegisch, Guenter, Albers, Peter, Buonerba, Carlo, di Lorenzo, Giuseppe, Vaishampayan, Ulka N., North, Scott A., Agarwal, Neeraj, Hussain, Syed A., Eigl, Bernhard J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913522/
https://ncbi.nlm.nih.gov/pubmed/26589729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.10.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados